Iovance Biotherapeutics Inc (IOVA)

09:29 AM

Iovance Biotherapeutics Stock Short Interest Falls to 32.69% - Quiver Quantitative

09:29 AM

May 04, 2026

IOVA Stock Rises As Rival’s FDA Setback Lifts Amtagvi - StocksToTrade

May 04, 2026

May 04, 2026

IOVA Stock Draws Bullish Calls As Rival Stumbles On FDA Setback - timothysykes.com

May 04, 2026

May 03, 2026

Iovance Biotherapeutics stock hits 52-week high at 4.35 USD - Investing.com

May 03, 2026

May 03, 2026

CM Management LLC Decreases Stock Holdings in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat

May 03, 2026

May 02, 2026

Iovance Biotherapeutics | ARS: Annual Report to Security Holders - Moomoo

May 02, 2026

May 02, 2026

This Beaten-Down Growth Stock Could Soar 165%, According to Wall Street - AOL.com

May 02, 2026

May 02, 2026

This Beaten-Down Growth Stock Could Soar 165%, According to Wall Street - The Motley Fool

May 02, 2026

May 01, 2026

IOVA stock slump takes Wall Street, retail by surprise — here’s why - MSN

May 01, 2026

May 01, 2026

Iovance’s Plan to Lift Authorized Shares to 650 Million Could Be A Game Changer For Iovance Biotherapeutics (IOVA) - Sahm

May 01, 2026

May 01, 2026

[ARS] IOVANCE BIOTHERAPEUTICS, INC. SEC Filing - Stock Titan

May 01, 2026

May 01, 2026

MSN Money - MSN

May 01, 2026

May 01, 2026

IOVA Earnings History & Surprises | EPS & Revenue Results | IOVANCE BIOTHERAPEUTICS INC (NASDAQ:IOVA) - ChartMill

May 01, 2026

Apr 30, 2026

Iovance Biotherapeutics senior executive joins cancer research panel to promote flexible innovation in immunotherapy - Traders Union

Apr 30, 2026

Apr 30, 2026

Iovance Biotherapeutics (IOVA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Apr 30, 2026

Apr 30, 2026

Iovance Biotherapeutics (IOVA) to Post Earnings on Thursday - MarketBeat

Apr 30, 2026

Apr 29, 2026

Iovance Share Increase Proposal Weighs Dilution Risk Against TIL Growth Funding - Yahoo Finance

Apr 29, 2026

Apr 28, 2026

Iovance Biotherapeutics | DEFA14A: Others - Moomoo

Apr 28, 2026

Apr 28, 2026

Iovance Biotherapeutics | DEF 14A: Definitive information statements - Moomoo

Apr 28, 2026

Apr 28, 2026

Iovance (NASDAQ: IOVA) seeks approval to raise authorized common shares to 650M - Stock Titan

Apr 28, 2026

Apr 28, 2026

Iovance Biotherapeutics: Buy, Because Short-Term Competitor Is Out (NASDAQ:IOVA) - Seeking Alpha

Apr 28, 2026

Apr 28, 2026

Assessing Iovance Biotherapeutics (IOVA) Valuation After Recent Share Price Recovery And Undervalued Narrative - Sahm

Apr 28, 2026

Apr 27, 2026

IOVA shares jump 8% — what’s retail expecting? - MSN

Apr 27, 2026

Apr 27, 2026

May 7 at 8:30 ET: Iovance to give Q1 results and updates - Stock Titan

Apr 27, 2026

Apr 27, 2026

Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026 - Yahoo Finance

Apr 27, 2026

Apr 26, 2026

After IOVA stock’s best day in 2 years, analyst sees over 300% upside: Here’s why - MSN

Apr 26, 2026

Apr 26, 2026

REPL vs IOVA: FDA decision day could test biotech bulls’ conviction on these melanoma plays - MSN

Apr 26, 2026

Apr 26, 2026

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue Estimates - MSN

Apr 26, 2026

Apr 25, 2026

Iovance Biotherapeutics (IOVA) down 2.1% since last earnings report: Can it rebound? - MSN

Apr 25, 2026

Apr 24, 2026

Chardan Capital Maintains Iovance Biotherapeutics (IOVA) Buy Recommendation - MSN

Apr 24, 2026

Apr 24, 2026

Iovance falls after guidance cut, revenue miss - MSN

Apr 24, 2026

Apr 23, 2026

Will FDA’s RP1 Setback Refocus Iovance Biotherapeutics' (IOVA) Post-Checkpoint Melanoma Narrative? - Sahm

Apr 23, 2026

Apr 23, 2026

IOVA Forecast, Price Target & Analyst Ratings | IOVANCE BIOTHERAPEUTICS INC (NASDAQ:IOVA) - ChartMill

Apr 23, 2026

Apr 22, 2026

Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 7.4%Here's What Happened - MarketBeat

Apr 22, 2026

Apr 22, 2026

IOVA Stock Grinds Lower As Traders Watch Key Support - StocksToTrade

Apr 22, 2026

Apr 22, 2026

Iovance Biotherapeutics Inc (IOVA): Jefferies Draws Attention Amtagvi Drug - Insider Monkey

Apr 22, 2026

Apr 22, 2026

H.C. Wainwright Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $9 - Moomoo

Apr 22, 2026

Apr 22, 2026

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Apr 22, 2026

Apr 21, 2026

Iovance Biotherapeutics, Inc. Sued for Securities Law Violations - GuruFocus

Apr 21, 2026

Apr 21, 2026

Analysts Are Bullish on Top Healthcare Stocks: Definium Therapeutics (DFTX), Iovance Biotherapeutics (IOVA) - The Globe and Mail

Apr 21, 2026

Apr 20, 2026

Chardan Maintains a Buy on Iovance Biotherapeutics (IOVA) - Insider Monkey

Apr 20, 2026

Apr 20, 2026

Barclays Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $11 - Moomoo

Apr 20, 2026

Apr 17, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Apr 17, 2026

Apr 17, 2026

Iovance Biotherapeutics (NASDAQ: IOVA) seeks votes on ESPP + share increase - Stock Titan

Apr 17, 2026

Apr 17, 2026

Is Iovance Biotherapeutics (IOVA) Pricing In Its Rebound After Strong Year To Date Gains? - Yahoo Finance

Apr 17, 2026

Apr 17, 2026

Assessing Iovance Biotherapeutics (IOVA) Valuation After Recent Three Month Share Price Surge - Sahm

Apr 17, 2026

Apr 16, 2026

Chardan Capital Lowers Price Target for IOVA, Maintains Buy Rati - GuruFocus

Apr 16, 2026